We are pleased to present the findings from PricewaterhouseCoopers' (PwC) Canadian Life Sciences Industry Forecast 2009, completed in collaboration with BIOTECanada. This report is designed to help stakeholders in the Canadian life sciences and biotechnology industry understand the challenges and concerns of their peers, especially in light of recent economic conditions.
Canada's world-renowned life sciences and biotechnology companies are proven leaders in innovation, but they also face increasing global competition and challenging economic conditions. Tightening credit has further limited access to capital, while the volatility in the markets increases valuation risk, putting pressure on share prices and asset values.
Through an online survey conducted in October and November 2008, 167 stakeholders from corporate, academic, government and other organizations in the Canadian life sciences and biotechnology industry were asked a series of questions intended to capture their thoughts on a variety of issues impacting the industry today and in the future.
This is our third report and our findings continue to build on the findings from our 2006 and 2007 Forecast Reports. In our view, the data gathered provides important information on where efforts should be placed to improve Canadian success. We trust you will find the information valuable for broadening the dialogue on these issues.
Download reports from previous years.
Publications Search Page
